Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumorsSamuel Cheshier, Siddhartha S. Mitra, Abdullah H. Feroze et al.|Science Translational Medicine|2017Cited by 427
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrenceRadhika Mathur, J Costello, Yalan Zhang et al.|Neuro-Oncology|2020Cited by 96
Advancing presurgical non-invasive molecular subgroup prediction in medulloblastoma using artificial intelligence and MRI signaturesYan-Ran Wang, Jian Gong, Peng Li et al.|Cancer Cell|2024Cited by 24